BIO B — Bio-Rad Laboratories Share News
0.000.00%
Last trade - 00:00- $9.75bn
- $9.34bn
- $2.58bn
Factbox: US companies announce layoffs to cut costs
Life sciences firms climb after US and China agree to cut tariffs
Life sciences firms rise after US and China agree to cut tariffs
Bio Rad Laboratories Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Bio-Rad To Report First Quarter 2025 Financial Results On Thursday, May 1, 2025
Life sciences firms jumps after Trump announces 90-day tariff pause
U.S. STOCKS ON THE MOVE-Walmart, Ford Motor, Starbucks
Factbox: US companies announce layoffs to cut costs
Bio-Rad sued by Caltech over DNA analysis technology
U.S. STOCKS ON THE MOVE-Meta Platforms, Dexcom, Dell
Bio-Rad Laboratories down after Q4 sales miss
Brief: Bio - Restructuring Plan To Eliminate Approximately 5% Of Workforce
Brief: Bio-Rad Offers To Acquire Digital Pcr Developer Stilla Technologies
Bio Rad Laboratories Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Bio-Rad Q4 Adjusted EPS USD 2.9 Vs. IBES Estimate USD 2.87
Brief: Geneoscopy Closes $105M In Series C Funding Round
Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit
Brief: Bio-Rad Q3 Adjusted EPS USD 2.01 Vs. IBES Estimate USD 1.16
What to Watch in the Day Ahead - Thursday, October 24